StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

3-Hydroxyisovaleric acid

HCID 69362
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
625-08-1
Standard-SMILES
CC(C)(O)CC(=O)O
InChIKey
AXFYFNCPONWUHW-UHFFFAOYSA-N
Summenformel
C5H10O3
Durchschnittliche Molmasse
118,13 g/mol
Monoisotopische Masse
118,06299418

Überblick

3-hydroxyisovaleric acid is a 3-hydroxy monocarboxylic acid that is isovaleric acid substituted at position 3 by a hydroxy group. Used as indicator of biotin deficiency. It has a role as a human metabolite. It is functionally related to an isovaleric acid and a butyric acid. It is a conjugate acid of a 3-hydroxyisovalerate.

Namen und Bezeichner

Bevorzugter Name
3-Hydroxyisovaleric acid
IUPAC
3-hydroxy-3-methylbutanoic acid
Englischer Name
beta-Hydroxyisovaleric Acid
Summenformel
C5H10O3
Molmasse
118.13

Namen und Synonyme

beta-Hydroxyisovaleric acid625-08-13-Hydroxy-3-methylbutanoic acid3-Hydroxyisovaleric acid3-Hydroxy-3-methylbutyric acid3-OH-isovaleric acid3-hydroxy-3-methyl-butanoic acid3-hydroxy-isovaleric acidHmb-d6beta-Hydroxy-methylbutyratebeta-hydroxy-beta-methylbutyric acidDTXSID20211535
Weitere Namen anzeigen
3-HYDROXY-3-METHYL BUTYRIC ACIDβ-Hydroxyisovaleric AcidRARECHEM AL BO 2324Beta-hydroxyic acidHYDROXY-METHYLBUTYRATE3-hydroxyisovalericaci
3F752311CDCHEBI:37084RefChem:911412beta hydroxy beta methylbutyratebeta-hydroxy beta-methylbutyrateDTXCID50134026626-699-8B-hydroxyisovaleric acid

Datenbank-Bezeichner

CAS
625-08-1
PubChem CID
69362
DTXSID
DTXSID20211535

Eigenschaften

Berechnete Struktureigenschaften

XLogP
-0,3
Polarare Oberfläche (TPSA)
57,5 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
2
Schwere Atome
8
Formalladung
0
Komplexität
95,8

Experimentelle und physikochemische Eigenschaften

LipidsFatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Hydroxy fatty acids [FA0105]
SpringerMaterials PropertiesOptical coefficient
LogP6.300
Melting Point65 - 67 °C
Physical DescriptionSolid

Physikochemische Eigenschaften

Schmelzpunkt
80 °C · −80 °C (−112 °F) (glass)
Siedepunkt
128 °C · 128 °C (262 °F) at 7 mmHg
Dichte
1.1 g/cm3 · ~1.1 g/cm3 at 20 °C
Brechungsindex
1.44 · 1.44
Flammpunkt
113 °C · 113 °C - closed cup
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
Löslichkeit
10 · DMF:10.0(Max Conc. mg/mL);84.65(Max Conc. mM)DMSO:10.0(Max Conc. mg/mL);84.65(Max Conc. mM)Ethanol:10.0(Max Conc. mg/mL);84.65(Max Conc. mM)PBS (pH 7.2):10.0(Max Conc. mg/mL);84.65(Max Conc. mM)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 48 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Toxikologische Informationen

Health Effects · 1 Eintrag

Chronically high levels of 3-hydroxyisovaleric acid are associated with at least 4 inborn errors of metabolism including: 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Methylglutaconic Aciduria Type I, Biotinidase deficiency and Isovaleric Aciduria.

Toxicity Summary · 1 Eintrag

3-Hydroxyisovaleric acid is a normal human metabolite excreted in the urine. Elevated levels of this compound are found in several disorders due to impairment of renal reclamation of biotin. Levels may also be increased from prolonged consumption of raw egg-whites.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Sicherheitsdaten

F
10-13-21

Chemie und Industrie

Pharmakologische Informationen

Tissue LocationsFibroblasts
Cellular LocationsCytoplasm

Verwendung und Herstellung

UsesThis is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.
Anwendungen · 2 Einträge

Beschreibungβ-Hydroxy β-methylbutyric acid (HMB), or β-hydroxy β- methylbutyrate, is a metabolite of the essential amino acid leucine and is synthesized in the human body. It plays a part in protein synthesis and was discovered by Dr. Steven L. Nissen at Iowa State University. It has been used in scientific studies to purportedly increase muscle mass and decrease muscle breakdown. Nissen held the original patent on the metabolite as a nutritional supplement. It was discovered in pigs, and small quantities can also be found in grapefruit, alfalfa, and catfish. As a supplement it is usually sold as a calcium salt. Research published in the Journal of Applied Physiology has shown that HMB may have an effect on increasing muscle weight and strength. A review in Nutrition & Metabolism provides an in depth and objective analysis of HMB research. The same study lists as HMB' s proposed mechanisms of action the following: Increased sarcolemmal integrity via conversion to HMG-CoA Enhanced protein synthesis via the mTOR pathway Depression of protein degradation through inhibition of the ubiquitin pathway Three grams of Calcium beta-hydroxy-beta-methylbutyrate per day may help muscles combat protein breakdown, assist in muscle repair and support increased endurance. Studies suggest its benefits may be greater for the untrained. Also, well-controlled scientific studies have found increases in muscle mass and decreases in body fat in 70 year old men. It has helped patients with chronic obstructive pulmonary disease in hospital intensive care units, muscle wasting associated with HIV or AIDS and with cancer, and trauma victims with severe injuries. The human body produces about 0.2 - 0.4 grams per day. Standard doses in research studies have been 1.5 to 3.0 grams per day, usually divided into two doses.

Zugehörige Reaktionen

37
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 331472
HRID 331472als Edukt
Reaktionsgleichung von HRID 374391
HRID 374391als Edukt
Reaktionsgleichung von HRID 374392
HRID 374392als Edukt
Reaktionsgleichung von HRID 421389
HRID 421389als Edukt
Reaktionsgleichung von HRID 546051
HRID 546051als Edukt
Reaktionsgleichung von HRID 628184
HRID 628184als Edukt
Reaktionsgleichung von HRID 628185
HRID 628185als Edukt
Reaktionsgleichung von HRID 670792
HRID 670792als Edukt
ZurückSeite 1 von 5

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
ChEMBL
CHEMBL4303793
ChEBI
CHEBI:37084
UNII
3F752311CD
EC Number
626-699-8
Nikkaji
J100.466B
pka
4.38 · 4.38±0.10(Predicted)
Aggregatzustand
clear liquid
Farbe
Colorless to Light yellow to Light orange
Wichte
1.1 · 1.10
Wasserlöslichkeit
Soluble in water and ethanol.
BRN
1743952 · 1743952
Kosmetik-Inhaltsstoffe Funktionen
ANTIOXIDANT
InChI
1S/C5H10O3/c1-5(2,8)3-4(6)7/h8H,3H2,1-2H3,(H,6,7)
InChIKey
AXFYFNCPONWUHW-UHFFFAOYSA-N
SMILES
CC(C)(O)CC(O)=O
CAS Datenbank
625 · 625-08-1(CAS DataBase Reference)
wgk
3
ridadr
UN 3334
hs_code
2918190090
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36
Speicherklasse
10 - Combustible liquids
Hazard Classifications
Eye Irrit. 2Skin Irrit. 2STOT SE 3

Verwendenβ-Hydroxyisovaleric Acid is a metabolite of the essential amino acid Leucine and is synthesized in the human body. Studies suggest that β-Hydroxyisovaleric Acid may have an effect on increasing muscle weight and strength. The presence of elevated β-Hydroxyisovaleric Acid is a sensitive marker of biotin deficiency and may indicate the presence of a genetic disorder such as biotinidase deficiency or holocarboxylase synthetase deficiency.

Vor- und nachgelagerte Produkte

Nachgelagerte Produkte

3-Methyl-1,3-butanediol

Ergänzende Hinweise

DefinitionChEBI: A 3-hydroxy monocarboxylic acid that is isovaleric acid substituted at position 3 by a hydroxy group. Used as indicator of biotin deficiency.